Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations

Cancer Control

Volumn 11, Issue 4, 2004, Pages 236-244

  Kelly, Kimberly ^a   Leventhal, Howard ^b   Marvin, Monica ^c   Toppmeyer, Deborah ^d   Baran, Jill ^d   Schwalb, Marvin ^e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Hlth Care Plcy   (United States)

^c SPECTRUM HEALTH   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; ASHKENAZI JEW; ATTITUDE; BREAST CANCER; CANCER GENETICS; DECISION MAKING; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; JEW; MALE; MULTIPLE CANCER; NORMAL HUMAN; ONCOGENE; OVARY CANCER; TUMOR SUPPRESSOR GENE;

EID: 3242745976     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480401100405     Document Type: Article

References (35)

1. Easton DF, Ford D, Bishop T, et al. Breast and ovarian cancer incidence in BRCA1: mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995;56:265-271.
2. Oddoux C, Struewing JP, Clayton CM, et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet. 1996;14:188-190.
3. Lancaster JM, Wooster R, Mangion J, et al. BRCA2 mutations in primary breast and ovarian cancers. Nat Genet. 1996;13:238-240.
4. Roa BB, Boyd AA, Volcik K, et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 1996;14:185-187.
5. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336:1401-1408.
6. Fitzgerald MG, MacDonald DJ, Krainer M, et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996;334:143-149.
7. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996;275:1885-1892.
8. Benkendorf JL, Reutenauer JE, Hughes CA, et al. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am J Med Genet. 1997;73:296-303.
9. Bluman LG, Rimer BK, Berry DA, et al. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol. 1999;17:1040-1046.
10. Kinney AY, Croyle RT, Dudley WN, et al. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev Med. 2001;33:543-551.
11. Lerman C, Biesecker B, Benkendorf JL, et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst. 1997;89:148-157.
12. Schwartz MD, Benkendorf J, Lerman C, et al. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women. Cancer. 2001;92:932-940.
13. Skinner CS, Schildkraut JM, Berry D, et al. Pre-counseling education materials for BRCA testing: does tailoring make a difference? Genet Test. 2002;6:93-105.
14. Randall J, Butow P, Kirk J, et al. Psychological impact of genetic counseling and testing in women previously diagnosed with breast cancer. Intern Med J. 2001;31:397-405.
15. Hughes C, Gomez-Caminero A, Benkendorf J, et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns. 1997;32:51-62.
16. Press NA, Yasui Y, Reynolds S, et al. Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. Am J Med Genet. 2001;99:99-110.
17. Ankori Z. Origins and history of Ashkenazi Jewry (8th to 18th century). In: Goodman RM, Motulsky AG, eds. Genetic Diseases Among Ashkenazi Jews. New York, NY: Raven Press; 1979.
18. Cappelli M, Surh L, Humphreys L, et al. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin Genet. 1999;55:419-430.
19. Petersen GM, Larkin E, Codori AM, et al. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients. Cancer Epidemiol Biomarkers Prev. 1999;8(4 pt 2):337-344.
20. Armstrong K, Weber B, Ubel PA, et al. Interest in BRCA1/2 testing in a primary care population. Prev Med. 2002;34:590-595.
21. Andrykowski MA, Munn RK, Studts JL. Interest in learning of personal genetic risk for cancer: a general population survey. Prev Med. 1996;25:527-536.
22. Ostrer H. A genetic profile of contemporary Jewish populations. Nat Rev Genet. 2001;2:891-898.
23. Goodman RM. A perspective on genetic diseases among the Jewish people. In: Goodman RM, Motulsky AG, eds. Genetic Diseases Among Ashkenazi Jews. New York, NY: Raven Press; 1979.
24. Rothenberg KH, Rutkin AB. Toward a framework of mutualism: the Jewish community in genetics research. Community Genet. 1998;1:148-153.
25. Phillips KA, Warner E, Meschino WS, et al. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2. Clin Genet. 2000;57:376-383.
26. National Society of Genetic Counselors: Familial Cancer Risk Counseling Association (members only). Standard Protocol. 2003. Available at: http://www.nsgc.org. Accessed May 3, 2004.
27. Tonin P, Weber B, Offit K, et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med. 1996;2:1179-1183.
28. Berry DA, Parmigiani G, Sanchez J, et al. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst. 1997;89:227-238.
29. Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet. 1998;62:145-158.
30. Euhus D. Cancer Gene Software [computer software]. Version 2.1. Dallas, Tex: University of Texas Southwestern Medical Center at Dallas; 1998. http://www3.utsouthwestern.edu/cancergene/
31. Flesch RF. A new readability yardstick. J Appl Psychol. 1948;32:221-233.
32. Kincaid JP, Fishburne RP Jr, Rogers RL, et al. Derivation of new readability formulas (Automated Readability Index, Fog Count and Flesch Reading Ease Formula) for Navy enlisted personnel. Research Branch Report 8-75. Millington, Tenn: Naval Technical Training, US Naval Air Station Memphis.
33. Bodd TL, Reichelt J, Heimdal K, et al. Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway. J Genet Couns. 2003;12:405-417.
34. Westman J, Hampel H, Bradley T. Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet. 2000;37:354-360.
35. McInerney J. Education in a genomic world. J Med Philos. 2002;27:369-390.